These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

253 related articles for article (PubMed ID: 3927508)

  • 21. Cleavage of human von Willebrand factor by platelet calcium-activated protease.
    Kunicki TJ; Montgomery RR; Schullek J
    Blood; 1985 Feb; 65(2):352-6. PubMed ID: 2981585
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Heightened interaction between platelets and factor VIII/von Willebrand factor in a new subtype of von Willebrand's disease.
    Ruggeri ZM; Pareti FI; Mannucci PM; Ciavarella N; Zimmerman TS
    N Engl J Med; 1980 May; 302(19):1047-51. PubMed ID: 6767976
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Association between bleeding time and platelet adherence to artery subendothelium.
    Sakariassen KS; Bolhuis PA; Blombäck M; Thorell L; Blombäck B; Sixma JJ
    Thromb Haemost; 1984 Oct; 52(2):144-7. PubMed ID: 6441301
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Abnormal VIII: von Willebrand factor patterns in the plasma of patients with the hemolytic-uremic syndrome.
    Moake JL; Byrnes JJ; Troll JH; Rudy CK; Weinstein MJ; Colannino NM; Hong SL
    Blood; 1984 Sep; 64(3):592-8. PubMed ID: 6432074
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Plasma collagen cofactor correlates with von Willebrand factor antigen and ristocetin cofactor but not with bleeding time.
    Aihara M; Kimura A; Chiba Y; Yoshida Y
    Thromb Haemost; 1988 Jun; 59(3):485-90. PubMed ID: 3142084
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Characterization of factor VIII/von Willebrand factor concentrates using a modified method of von Willebrand factor multimer analysis.
    Metzner HJ; Hermentin P; Cuesta-Linker T; Langner S; Müller HG; Friedebold J
    Haemophilia; 1998; 4 Suppl 3():25-32. PubMed ID: 10028315
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Von Willebrand disease--a variation with an aberrant multimeric structure].
    Batlle Fonrodona J; López Fernández MF; Fernández Villamor A; López Berges C; Lasierra Cirujeda J; López Borrasca A
    Sangre (Barc); 1985; 30(2):146-53. PubMed ID: 3925572
    [No Abstract]   [Full Text] [Related]  

  • 28. Abnormal antigenic reactivity of factor VIII/von Willebrand factor subunit in variants of von Willebrand's disease.
    Girma JP; Pietu G; Lavergne JM; Meyer D; Larrieu MJ
    J Lab Clin Med; 1982 Apr; 99(4):481-94. PubMed ID: 6174657
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Factor VIII/von Willebrand factor complex (FVIII/vWF)].
    Yoshioka A
    Rinsho Byori; 1985 Feb; Spec No 61():73-85. PubMed ID: 3923232
    [No Abstract]   [Full Text] [Related]  

  • 30. Platelet von Willebrand factor in Hermansky-Pudlak syndrome.
    McKeown LP; Hansmann KE; Wilson O; Gahl W; Gralnick HR; Rosenfeld KE; Rosenfeld SJ; Horne MK; Rick ME
    Am J Hematol; 1998 Oct; 59(2):115-20. PubMed ID: 9766795
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Analysis of platelet von Willebrand factor antigen.
    Thomas KB; Firkin BG; Howard MA
    Haemostasis; 1987; 17(4):217-25. PubMed ID: 3623266
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Time course of changes in in vitro platelet function and plasma von willebrand factor activity (VIIIR:WF) and factor VIII-related antigen (VIIIR:Ag) in the diabetic rat.
    Winocour PD; Lopes-Virella M; Laimins M; Colwell JA
    J Lab Clin Med; 1983 Nov; 102(5):795-804. PubMed ID: 6415193
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Multimers of von Willebrand antigen in therapeutic factor VIII concentrates.
    Vukovich TC
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1986; 113(6):831-40. PubMed ID: 2436998
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Increased factor VIII/vWf levels in patients with reduced platelet number.
    Casonato A; Fabris F; Boscaro M; Girolami A
    Blut; 1987 May; 54(5):281-8. PubMed ID: 3105627
    [TBL] [Abstract][Full Text] [Related]  

  • 35. In vitro correction of the abnormal multimeric structure of von Willebrand factor in type IIa von Willebrand's disease.
    Gralnick HR; Williams SB; McKeown LP; Maisonneuve P; Jenneau C; Sultan Y; Rick ME
    Proc Natl Acad Sci U S A; 1985 Sep; 82(17):5968-72. PubMed ID: 2994057
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Multimeric pattern of plasma and platelet von Willebrand factor is normal in uremic patients.
    Castaman G; Rodeghiero F; Lattuada A; La Greca G; Mannucci PM
    Am J Hematol; 1993 Dec; 44(4):266-9. PubMed ID: 8237998
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Comparative analysis and classification of von Willebrand factor/factor VIII concentrates: impact on treatment of patients with von Willebrand disease.
    Budde U; Metzner HJ; Müller HG
    Semin Thromb Hemost; 2006 Sep; 32(6):626-35. PubMed ID: 16977573
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Plasma and platelet von Willebrand factor defects in uremia.
    Gralnick HR; McKeown LP; Williams SB; Shafer BC; Pierce L
    Am J Med; 1988 Dec; 85(6):806-10. PubMed ID: 3264111
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Is the pro-adhesive activity of plasma von Willebrand factor counteracted by a physiological inhibitor of platelet adhesiveness?
    Porta M; Cagliero E; Kohner EM
    Clin Sci (Lond); 1982 Feb; 62(2):239-42. PubMed ID: 6797774
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Participation of von Willebrand factor in blood platelet functions].
    Mikami S; Takahashi Y; Nishino M; Fukui H
    Nihon Rinsho; 1978 Dec; 36(12):3824-9. PubMed ID: 372620
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.